STOCK TITAN

Recursion (NASDAQ: RXRX) director sells, gifts and converts shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Recursion Pharmaceuticals director Christopher Gibson reported multiple stock movements in Class A and Class B shares. He sold 40,000 shares of Class A Common Stock at $3.37 per share in an open-market transaction and made a bona fide gift of 20,000 shares, both on May 7, 2026, under a pre-arranged Rule 10b5-1 trading plan. He also converted 60,000 shares of Class B Common Stock into 60,000 shares of Class A Common Stock. After these transactions, he directly holds 906,556 shares of Class A Common Stock. The filing also lists several outstanding stock option awards with exercise prices between $2.48 and $10.09, expiring between 2030 and 2035, and indirect holdings of Class B shares through family entities.

Positive

  • None.

Negative

  • None.
Insider Gibson Christopher
Role null
Sold 40,000 shs ($135K)
Type Security Shares Price Value
Conversion Class B Common Stock 60,000 $0.00 --
Conversion Class A Common Stock 60,000 $0.00 --
Sale Class A Common Stock 40,000 $3.37 $135K
Gift Class A Common Stock 20,000 $0.00 --
holding Class B Common Stock -- -- --
holding Class B Common Stock -- -- --
holding Class B Common Stock -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
Holdings After Transaction: Class B Common Stock — 4,343,334 shares (Direct, null); Class A Common Stock — 966,556 shares (Direct, null); Class B Common Stock — 0 shares (Indirect, by LAHWRAN-3 LLC); Stock Option (Right to Buy) — 0 shares (Direct, null)
Footnotes (1)
  1. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025. The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager. The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager. The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee. The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter. The option vests as to one forty-eighth (1/48th) of the original 666,898 shares subject to the option on March 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter. The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter. The option, originally for 416,350 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter. The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
Shares sold 40,000 shares Class A Common Stock sold at $3.37 on May 7, 2026
Sale price $3.37/share Open-market or private sale of Class A shares
Shares gifted 20,000 shares Bona fide gift of Class A Common Stock on May 7, 2026
Shares converted 60,000 shares Class B Common Stock converted into Class A Common Stock
Direct holdings after transactions 906,556 shares Class A Common Stock directly owned after May 7, 2026
Lowest option exercise price $2.48 Stock option on Class A Common Stock expiring December 30, 2030
Highest option exercise price $10.09 Stock option on Class A Common Stock expiring February 9, 2034
Rule 10b5-1 trading plan financial
"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
bona fide gift financial
"transaction_code_description": "Bona fide gift""
A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.
derivative security financial
"transaction_code_description": "Conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
Class B Common Stock financial
"Each share of Class B Common Stock is convertible into one share of Class A Common Stock"
A class B common stock is one of multiple types of a company’s ordinary shares that carries specific rights—often different voting power or dividend priority—compared with other classes. For investors it matters because those differences affect how much influence you have over company decisions, the income you might receive, and how freely the shares trade; think of it like owning a car with different keys: some keys let you start the engine and open the trunk, others only unlock the door.
stock option (Right to Buy) financial
"security_title": "Stock Option (Right to Buy)""
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Gibson Christopher

(Last)(First)(Middle)
C/O RECURSION PHARMACEUTICALS
41 S. RIO GRANDE STREET

(Street)
SALT LAKE CITY UTAH 84101

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
RECURSION PHARMACEUTICALS, INC. [ RXRX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/07/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock05/07/2026C(1)(2)60,000A$0966,556D
Class A Common Stock05/07/2026S(2)40,000D$3.37926,556D
Class A Common Stock05/07/2026G(2)20,000D$0906,556D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Class B Common Stock$0(1)05/07/2026C(1)(2)60,000 (1) (1)Class A Common Stock60,000$04,343,334D
Class B Common Stock$0 (1) (1)Class A Common Stock0386,000Iby LAHWRAN-3 LLC(3)
Class B Common Stock$0 (1) (1)Class A Common Stock0388,000Iby LAHWRAN-4 LLC(4)
Class B Common Stock$0 (1) (1)Class A Common Stock050,000Iby Gibson Family Trust(5)
Stock Option (Right to Buy)$7.25 (6)02/03/2035Class A Common Stock01,050,567D
Stock Option (Right to Buy)$10.09 (7)02/09/2034Class A Common Stock0666,898D
Stock Option (Right to Buy)$8.55 (8)02/01/2033Class A Common Stock0813,600D
Stock Option (Right to Buy)$11.4 (9)02/04/2032Class A Common Stock0399,002D
Stock Option (Right to Buy)$11.402/04/202202/04/2032Class A Common Stock05,436D
Stock Option (Right to Buy)$2.48 (10)12/30/2030Class A Common Stock0282,500D
Explanation of Responses:
1. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
2. This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025.
3. The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.
4. The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.
5. The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.
6. The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
7. The option vests as to one forty-eighth (1/48th) of the original 666,898 shares subject to the option on March 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
8. The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
9. The option, originally for 416,350 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
10. The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
Remarks:
/s/Jonathan Golightly, attorney-in-fact05/07/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did RXRX director Christopher Gibson report?

Christopher Gibson reported a mix of transactions: an open-market sale of 40,000 Class A shares at $3.37, a bona fide gift of 20,000 Class A shares, and the conversion of 60,000 Class B shares into Class A on May 7, 2026.

How many Recursion Pharmaceuticals (RXRX) shares does Christopher Gibson hold after these trades?

After the reported transactions, Christopher Gibson directly holds 906,556 shares of Class A Common Stock. He also has indirect interests in Class B Common Stock through the Gibson Family Trust and LAHWRAN-3 and LAHWRAN-4 LLCs, as described in the filing footnotes.

Was the RXRX insider sale by Christopher Gibson pre-planned under Rule 10b5-1?

Yes. A footnote states the transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Christopher Gibson on May 12, 2025. Such plans pre-schedule trades, indicating the timing of the 40,000-share sale was decided in advance.

What price did Christopher Gibson receive for the RXRX shares he sold?

He sold 40,000 shares of Class A Common Stock at an average price of $3.37 per share. This open-market or private transaction is coded as an “S” transaction in the Form 4, indicating a sale rather than a purchase or grant.

What is the significance of the Class B to Class A share conversion for RXRX?

Gibson converted 60,000 Class B Common Stock shares into 60,000 Class A shares. Each Class B share is convertible into one Class A share with no expiration date, so the conversion changes share class and voting mix but not the total number of shares he beneficially owns.

What stock options for RXRX does Christopher Gibson have according to this filing?

The filing lists several stock option awards on Class A Common Stock with exercise prices from $2.48 to $10.09, expiring between 2030 and 2035. Footnotes describe monthly vesting in forty‑eighths starting on various March or January vesting commencement dates.